AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice.
AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice.
复制标题
DOI:
10.1016/j.celrep.2016.09.082
复制
发表时间:
2016-10-25
期刊:
影响因子:
8.8
通讯作者:
Quintana FJ
中科院分区:
文献类型:
--
作者:
Goettel JA;Gandhi R;Kenison JE;Yeste A;Murugaiyan G;Sambanthamoorthy S;Griffith AE;Patel B;Shouval DS;Weiner HL;Snapper SB;Quintana FJ
Existing therapies for inflammatory bowel disease based on broad suppression of inflammation result in variable clinical benefit and unwanted side effects. A potential therapeutic approach for promoting immune tolerance is the in vivo induction of regulatory T cells (Tregs). Here we report that activation of the aryl hydrocarbon receptor using the non-toxic agonist 2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE) induces human Tregs in vitro that suppress effector T cells through a mechanism mediated by CD39 and Granzyme B. We then developed a humanized murine system whereby human CD4+ T cells drive colitis upon exposure to 2,4,6-trinitrobenzenesulfonic acid and assessed ITE as a potential therapeutic. ITE administration ameliorated colitis in humanized mice with increased CD39, Granzyme B, and IL-10-secreting human regulatory T cells. These results develop an experimental model to investigate human CD4+ T responses in vivo and identify the non-toxic AHR agonist ITE as a potential therapy for promoting immune tolerance in the intestine.
登录
查看更多内容
影响因子:
30.5
作者:
通讯作者:
--
影响因子:
24.5
作者:
Canavan JB;Scottà C;Vossenkämper A;Goldberg R;Elder MJ;Shoval I;Marks E;Stolarczyk E;Lo JW;Powell N;Fazekasova H;Irving PM;Sanderson JD;Howard JK;Yagel S;Afzali B;MacDonald TT;Hernandez-Fuentes MP;Shpigel NY;Lombardi G;Lord GM
通讯作者:
Lord GM
影响因子:
20.3
作者:
Borsellino, Giovanna;Kleinewietfeld, Markus;Falk, Kirsten
通讯作者:
Falk, Kirsten
影响因子:
56.9
作者:
Duerr, Richard H.;Taylor, Kent D.;Cho, Judy H.
通讯作者:
Cho, Judy H.
影响因子:
4.4
作者:
Chinen, Ichino;Nakahama, Taisuke;Kishimoto, Tadamitsu
通讯作者:
Kishimoto, Tadamitsu